Voorter C E, van der Vlies S, Kik M, van den Berg-Loonen E M
Tissue Typing Laboratory, University Hospital, Maastricht, The Netherlands.
Tissue Antigens. 2000 Oct;56(4):363-70. doi: 10.1034/j.1399-0039.2000.560409.x.
The Bw4 and Bw6 epitopes were the first HLA-B differences to be recognized by serological methods. Since then 44 serological groups have been identified and more than 250 alleles assigned by molecular typing methods. In general each serological HLA-B group is associated with the presence of either the Bw4 or the Bw6 epitope. There are several exceptions to this rule. Four alleles, B4601, 7301, 5503 and 1806, show no serological reactivity with either Bw4 or Bw6. Although the Bw6 motif at residues 77-83 is present in these alleles the Bw6 epitope is modified by a valine at residue 76. One or more alleles from the B8, B40 and B62 groups are identified as Bw4 positive, whereas all others are Bw6 positive. In the groups B27, B44 and B47 several alleles are found to be Bw6 positive, while the majority is Bw4 positive. Histocompatibility testing of dialysis patients and their families revealed the serological presence of an unexpected Bw4 epitope associated with B18 in one patient and B56 in another. Allele-specific amplification and sequencing of exons 2 and 3 of these HLA-B alleles revealed the presence of the Bw4 sequence motif for both. The new alleles were assigned B1809 and B5607, respectively. In 2 other patients the presence of a new B07 allele was determined by sequence based typing. Although the new allele, B0715, showed the Bw6 sequence motif at positions 77 to 83, a substitution of amino acid 76 from glutamic acid to valine was identified. This change resulted in an aberrant Bw6 serological reaction pattern.
Bw4和Bw6表位是首批通过血清学方法识别出的HLA - B差异。自那时起,已鉴定出44个血清学组,并通过分子分型方法确定了250多个等位基因。一般来说,每个血清学HLA - B组都与Bw4或Bw6表位的存在相关。这条规则有几个例外情况。四个等位基因B4601、7301、5503和1806,与Bw4或Bw6均无血清学反应性。尽管这些等位基因在第77 - 83位残基处存在Bw6基序,但Bw6表位在第76位残基处被缬氨酸修饰。来自B8、B40和B62组的一个或多个等位基因被鉴定为Bw4阳性,而其他所有等位基因均为Bw6阳性。在B27、B44和B47组中,发现有几个等位基因是Bw6阳性,而大多数是Bw4阳性。对透析患者及其家属进行的组织相容性检测显示,在一名患者中血清学检测到与B18相关的意外Bw4表位,在另一名患者中检测到与B56相关的意外Bw4表位。对这些HLA - B等位基因的第2和第3外显子进行等位基因特异性扩增和测序,结果显示两者均存在Bw4序列基序。新等位基因分别被命名为B1809和B5607。在另外两名患者中,通过基于序列的分型确定存在一个新的B07等位基因。尽管新等位基因B0715在第77至83位显示出Bw6序列基序,但发现第76位氨基酸从谷氨酸替换为缬氨酸。这种变化导致了异常的Bw6血清学反应模式。